Biological/Vaccine, Non-Stem Cell : Patients completed all cycles of induction treatment including chemotherapy, radiotherapy, and/or high-dose therapy followed by stem cell transplantation (HDT/SCT

2 trials

Sponsors

The Catholic University of Korea, Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul St. Mary's Hospital

Phase 1

The safety and efficacy of EBV specific cytotoxic T cell in patients with EBV positive post-transplant lymphoproliferative disease

Active, not recruitingKCT0001996

The Catholic University of Korea, Seoul St. Mary's Hospital

Start: 2012-02-28Target: 2Updated: 2019-03-11

Phase 2

Safety and efficacy of administration of EBV specific cytotoxic T lymphocytes in chemotherapy responding EBV positive NK/T cell lymphoma patients.

Active, not recruitingKCT0001271

The Catholic University of Korea, Seoul St. Mary's Hospital

Start: 2007-07-31Target: 11Updated: 2019-03-11